Across TCGA pan-cancer cohorts, SNORA70H RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNORA70H’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SNORA70H RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORA70H is over-expressed in tumor.

BRCA, BLCA, and KIRC are the cancer types where SNORA70H tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNORA70H RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.099	.019	4	view →
BLCA	Male	All	+0.213	.028	2	view →
KIRC	All	All	+0.040	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SNORA70H RNA expression & survival · all SNORA70H data types